PATH EX, Inc.

📍 Houston, United States🗓 Founded 2017👥 8 employees💰 Last funded Apr 2025
Medical Equipment Manufacturing🌐 pathex.co
Website LinkedIn
PATH EX, Inc. is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections. The device has demonstrated promising outcomes in preclinical and clinical feasibility studies. PATH EX is advancing toward commercialization, aiming to revolutionize sepsis care and improve patient survival.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in PATH EX, Inc.?
PATH EX, Inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did PATH EX, Inc. last raise funding?
The most recent investment in PATH EX, Inc. recorded on gritt.io was in April 2025.
When was PATH EX, Inc. founded?
PATH EX, Inc. was founded in 2017.
What industry is PATH EX, Inc. in?
PATH EX, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is PATH EX, Inc. based?
PATH EX, Inc. is headquartered in Houston, United States.